drugset / Trial / NCT07656688

Dose-Finding Study of HUC1-394 in Participants With Dry Eye Disease

NCT07656688 ↗

Phase 2 Recruiting 150 enrolled Huons Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Clinical trial aims to determine the optimal dosing regimen by evaluating the efficacy and safety of HUC1-394 across different dosing frequencies in patients with moderate to severe dry eye disease.

Timeline

Start
2026-07
Primary completion
2027-06
Completion
2027-07

Drugs

EvaluationDrugModalityDoseRoute
Subject HUC1-394 Unknown — Other

Indications